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Abstract
The X chromosome is a key player in germ cell development, as has been highlighted for males in previous studies revealing 
that the mammalian X chromosome is enriched in genes expressed in early spermatogenesis. In this review, we focus on the 
X chromosome’s unique biology as associated with human male infertility. Male infertility is most commonly caused by 
spermatogenic defects to which X chromosome dosage is closely linked; for example, any supernumerary X chromosome as 
in Klinefelter syndrome will lead to male infertility. Furthermore, because males normally only have a single X chromosome 
and because X-linked genetic anomalies are generally only present in a single copy in males, any loss-of-function muta-
tions in single-copy X-chromosomal genes cannot be compensated by a normal allele. These features make X-linked genes 
particularly attractive for studying male spermatogenic failure. However, to date, only very few genetic causes have been 
identified as being definitively responsible for male infertility in humans. Although genetic studies of germ cell-enriched 
X-chromosomal genes in mice suggest a role of certain human orthologs in infertile men, these genes in mice and humans 
have striking evolutionary differences. Furthermore, the complexity and highly repetitive structure of the X chromosome hin-
der the mutational analysis of X-linked genes in humans. Therefore, we conclude that additional methodological approaches 
are urgently warranted to advance our understanding of the genetics of X-linked male infertility.
Introduction
Infertility is a frequent condition affecting one out of six 
couples in Western countries (Krausz and Riera-Escamilla 
2018). Male factors contribute to infertility in about 50% 
of cases and can be classified into four major etiological 
categories: (i) hypothalamic–pituitary axis dysfunction; (ii) 
quantitative alterations of spermatogenesis; (iii) qualitative 
alterations of spermatogenesis; and (iv) ductal obstruction/
dysfunction (Tournaye et al. 2016). Known genetic fac-
tors are present in each of these etiological categories, and, 
depending on the severity of the spermatogenic impairment, 
they account for about 10–20% of cases. With the advent of 
large-scale sequencing strategies (especially exome analysis 
by next-generation sequencing, or NGS), more and more 
novel genes have been reported to be linked with male infer-
tility. However, the majority of these genes still lack a defini-
tive gene–disease relationship (Oud et al. 2019). Further, 
about 40% of quantitative spermatogenic impairment cases 
cannot be causally diagnosed and are instead referred to as 
unexplained or idiopathic infertility; a large proportion of 
these cases are likely caused by yet unknown genetic factors.
Both sex chromosomes in males (X and Y) are enriched 
in genes specifically or overexpressed in the testis (Skaletsky 
et al. 2003; Mueller et al. 2008). Moreover, in males, de 
novo or rare mutations in these chromosomes may have a 
direct phenotypic effect because there is no second com-
pensatory X or Y allele. The role of Y chromosome-linked 
deletions in male infertility has been well understood since 
1996 (Vogt et al. 1996). Here, the removal of genes belong-
ing to the so-called azoospermia factor (AZF) region causes 
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azoospermia or oligozoospermia (Krausz et al. 2014; Krausz 
and Casamonti 2017). While screening for Y chromosome 
deletions is a fundamental part of the diagnostic workup of 
severe oligo/azoospermic men, only two X chromosome-
linked genes are routinely tested in selected pathological 
conditions (ANOS1 and AR). Thanks to high-throughput 
approaches such as whole exome sequencing (WES) and 
comparative genomic hybridization (CGH) arrays, novel 
X-linked gene mutations (e.g., TEX11 and ADGRG2) have 
been discovered as causative factors of different infertile 
phenotypes.
In light of these findings, in this review we will discuss (i) 
X-linked genes and male fitness from an evolutionary point 
of view; (ii) the clinical consequences of X-linked aneuploi-
dies and deletions; (iii) the role of X-linked gene mutations 
in male infertility.
Structure and function of the X chromosome
While both sex chromosomes are derived from a pair of 
autosomes around 300 million years ago, most ancestral 
functional elements have been only conserved on the X 
chromosome (Ross et al. 2005). The sex chromosome’s 
size also differs dramatically, and while the X chromosome 
has remained relatively stable in magnitude with around 
155 Mb, the Y chromosome decreased to around 55 Mb. The 
X chromosome contains about 800 (human) to 850 (murine) 
protein-coding genes (Mueller et al. 2013), for which a dis-
proportionately high number of inherited diseases were 
documented. The unique gene composition of the X chro-
mosome also allows balanced gene dosage compensation 
through a well-regulated spatial and temporal expression of 
X-linked genes (Deng et al. 2014).
The X chromosome was previously considered the most 
stable chromosome of the genome (Ohno 1967) and was 
largely perceived as a “female” counterpart to the “male” 
Y chromosome. But, to the contrary, it turns out that the X 
chromosome is in a current state of rapid evolution toward 
a specialized role for sperm production.
The hemizygosity in males allows for unique evolutionary 
patterns of X-linked genes for male sexual fitness and can 
favor positive selection of advantageous variants (Vicoso 
and Charlesworth 2006). Accordingly, the X chromosome 
is enriched for sex-biased (Khil et al. 2004) and spermatogo-
nia-expressed (Wang et al. 2001) genes. However, X-linked 
genes are thought to be silenced during male meiosis by a 
mechanism known as meiotic sex chromosome inactivation 
(Turner 2007). To compensate for this inactivation, large 
gene families with multiple copies have accumulated on the 
X chromosome (Warburton et al. 2004), and these homolo-
gous palindromic repeats are highly expressed in spermatids 
(Mueller et al. 2008). An example of an X-chromosomal 
multigene family is the large superfamily called cancer testis 
antigens (CTA), in which members are arranged into com-
plex direct and palindromic repeats. As has been estimated, 
CTA families account for around 10% of X-linked genes 
(Simpson et al. 2005; Almeida et al. 2009), and they can be 
divided into the MAGE multigene family and the NY-ESO-1 
family in region Xq24-q28 and the SSX family and GAGE/
PAGE/XAGE families in region Xp11 (Zendman et al. 2003). 
Most of the CTA genes are expressed during spermatogen-
esis, but their function in both germline tissues and tumors 
remains poorly understood (Fratta et al. 2011).
It has been speculated that multicopy regions on the X 
chromosome may have an important function for germ cell 
survival, e.g., through dosage compensation. In this regard, 
homologous repeats could self-pair during male meiosis 
such that they would potentially be protected from unpaired 
chromosome inactivation, as has been suggested for the 
Y chromosome (Skaletsky et al. 2003). However, a recent 
study implies that copy number expansions of palindro-
mic genes might not be essential for spermatogenesis, as 
reduced ampliconic gene expression following deletion of 
large X-linked palindromes did not reduce fertility in male 
mice (Kruger et al. 2018).
X chromosome‑linked genes and male 
fitness: an evolutionary perspective
More than 50 years ago, it was postulated that the X chro-
mosome is in an evolutionary stable state, and X-linked 
genes should differ little between placental mammals 
(Ohno 1967). This hypothesis, called ‘Ohno’s law’, is 
supported by several comparative mammalian studies 
(e.g., Murphy et al. 1999; Kuroiwa et al. 2001; Raudsepp 
et al. 2004; Ross et al. 2005). Later though, it was shown 
that X chromosomes have undergone rapid evolution-
ary changes, and accumulation of ampliconic genes has 
occurred individually during mammalian evolution (Bel-
lott et al. 2010; Mueller et al. 2013). This comparison of 
multicopy genes in different lineages has offered impor-
tant insights into the mammalian evolution of X-linked 
genes. While most of the single-copy genes on the mouse 
and human X chromosomes are conserved between these 
species, approximately 340 genes are not shared between 
the two species, and most of these unshared genes are 
found in ampliconic regions (Fig. 1). About 10% of the 
human and 16% of mouse X-linked genes, respectively, 
have been independently acquired since their divergence 
from a common ancestor. In contrast to the shared, single-
copy genes, these ampliconic genes are notable excep-
tions to the postulated Ohno’s law. Expression analyses 
further revealed that these ampliconic genes are active 
almost exclusively in testicular germ cells, but not in 
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other male tissues or female tissues. As such, they are 
likely to contribute to sperm production (Mueller et al. 
2013). Although the physiological functions of most inde-
pendently acquired, ampliconic genes are still unclear, 
their rapid evolution suggests a strong positive selection 
that may have contributed to speciation.
It is possible that these genes have significant roles in 
diseases related to infertility, but the use of model sys-
tems for these genes is complicated because they are not 
conserved in mice. This caveat seems to apply to all sex-
linked genes, as a recent study has suggested that sex bias 
in overall gene expression also arose recently in mam-
malian evolution and, hence, could be species specific, 
which might prevent results on molecular variation from 
being translated from animal models to human reproduc-
tion research (Naqvi et al. 2019). Furthermore, sex chro-
mosomes evolve functional specialization by accumula-
tion of sexually antagonistic as well as sex-biased genes 
(Vicoso and Charlesworth 2006; Parsch and Ellegren 
2013). The significant enrichment for testis-expressed 
genes on the X chromosome and the differential expres-
sion of sex-biased genes imply that sexual conflict has 
profound consequences on gene content evolution of X 
chromosomes in mammals (Gurbich and Bachtrog 2008; 
Larson et al. 2018).
The consequences of too much and too little 
X chromosome
Too much X: Klinefelter syndrome
Klinefelter syndrome (KS) is a chromosomal condition 
that was first described in 1942 (Klinefelter et al. 1942). 
It was not until 1959 when Jacobs and Strong (1959) 
determined that it was caused by the presence of an extra 
X chromosome. Various genotypes are associated with 
this condition, the most common being 47,XXY in up to 
80–90% of cases, while in approximately 10% of cases 
the genotype is a mosaic form of 47,XXY/46,XY. Other 
rare variants are 48,XXXY; 48,XXYY; 49,XXXXY; 
49,XXXYY; and 49,XXYYY and are associated with 
more severe phenotypes (Visootsak et al. 2001; Tartaglia 
et al. 2008; Ottesen et al. 2010). KS shows an estimated 
frequency of 1:600 in the general population, whereas in 
patients with non-obstructive azoospermia it is as high 
as 15%. In adults, the diagnosis is mainly made because 
of infertility and/or sexual dysfunction. The reproductive 
phenotype of these individuals includes small, firm testes 
with hyalinization of seminiferous tubules with consequent 
spermatogenic failure. In fact, over 90% of KS patients are 
Fig. 1  Evolution of mammalian X chromosomes. Contrary to 
Ohno’s law, the gene content of the X chromosomes differs signifi-
cantly within the mammalian lineage. a Schematics of the variability 
of X-linked genes between rodents and primates. Colors denote the 
divergent evolutionary origins of X-linked genes. Gray: conserved 
ancestral regions (corresponds to the long arm of the human X, and 
this region is rearranged in mice); Blue: acquired gene content in 
mammals (short arm of human X, region rearranged in mice); green 
and orange: independently acquired ampliconic genes in humans 
and mice, respectively (positions correspond to arbitrary genomic 
locations). b Depicted diagrams show a comparison of all X-linked 
(n = 800 human, 853 mouse) and predominantly testis-expressed 
genes (expression patterns of eight human tissues and three mouse 
tissues) in humans and mice. Bar graphs: percentages of protein-cod-
ing X-linked genes categorized as single copy (SC, blue), multicopy 
(MC, yellow) or ampliconic (AMP, red). Pie charts: percentages of 
X-linked genes that are shared (sh, light green) in both species or are 
independently acquired (ia, dark blue) after the divergence of humans 
and mice. Most ampliconic X-linked genes have been independently 
acquired in primates and rodents and are predominantly expressed 
in testes (data adopted from Bellott et al. 2010; Mueller et al. 2013; 
Deng et al. 2014)
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azoospermic, and the remaining show crypto/severe oligo-
zoospermia. Despite that spontaneous puberty is observed 
in these patients; the majority of them present signs of 
androgen deficiency, which range from hypogonadism 
with gynecomastia and eunuchoid proportions to variable 
levels of undervirilization.
Natural pregnancies have been reported mostly in mosaic 
KS cases. For the majority of non-mosaic 47,XXY KS men, 
conception of a biological child is only possible through tes-
ticular sperm extraction (TESE), either conventional TESE 
or microTESE combined with intracytoplasmic sperm injec-
tion (ICSI) (Corona et al. 2017). The success rate of sperm 
retrieval varies in different laboratories, but according to a 
recent meta-analysis the mean sperm retrieval rate (SRR) 
is about 44% (Corona et al. 2017). Although an accurate 
prediction of SRR is not possible, age seems to be a relevant 
prognostic parameter, and KS patients under 30 years old 
show a higher success rate (Rohayem et al. 2015). Hence, 
an early diagnosis of this syndrome is clearly relevant, 
since it would allow both the preservation of fertility and 
the introduction of preventive therapies to avoid or to better 
control associated co-morbidities. In fact, besides reproduc-
tive/sexual problems, KS patients may present a series of 
co-morbidities such as metabolic syndrome, autoimmune 
diseases, osteoporosis, breast and germ cell tumors, venous 
thromboembolisms and cognitive/psychiatric disturbances 
(Gravholt et al. 2018 and references therein).
What underlies the heterogeneous phenotypic presenta-
tion is still not clear, but is probably related to various fac-
tors (Tüttelmann and Gromoll 2010; Zitzmann et al. 2015). 
For instance, the proposed phenotypic modulators include 
parental origin of the extra X chromosome, the androgen 
receptor CAG repeat length, gene dosage dysregulation, 
and/or epigenetic events. First, the parental origin of the 
supernumerary X chromosome has only been addressed by 
few studies reporting a potential effect on impaired speech/
motor development (Stemkens et al. 2006), later onset of 
puberty (Wikstrom et al. 2006) and schizotypal traits (Bruin-
ing et al. 2010). While impaired speech/motor developmen-
tal problems and later onset of puberty were significantly 
associated with paternal origin of the X chromosome, sig-
nificantly higher scores on schizotypal traits were associated 
with maternal origin.
Next, regarding the CAG repeats in the androgen recep-
tor (AR) gene, the number modulates its transcriptional 
activity in vitro (Gao et al. 1996), and an increased num-
ber of repeats was positively correlated with height, arm 
span and both arm and leg length in KS patients (Zitzmann 
et al. 2004; Bojesen et al. 2011; Chang et al. 2015). On the 
other hand, data on the (CAG)n polymorphism in relation 
to testicular volume, gynecomastia, lipid metabolism and 
bone-related parameters are still controversial (Gravholt 
et al. 2018 and references therein).
Regarding dosage dysregulation, women have two X 
chromosomes, while men only have one. Thus, to compen-
sate for the difference in gene dosage, in females one of the 
two X chromosomes is inactivated. However, a small portion 
of X-chromosomal genes (~ 10–15%) escape inactivation, 
among it the PAR genes. In this regard, the overdosage of 
SHOX has been demonstrated to be associated with the typi-
cal excess height of KS patients. Apart from SHOX, other 
PAR genes such as CD99 and CSF2RA were found differen-
tially expressed in the KS group vs. male controls (Zitzmann 
et al. 2015). The overexpression of these two genes could 
contribute to the development of some of the typical co-
morbidities of KS [overexpression of CD99 was associated 
with inflammatory cytokines, whereas CSF2RA with insulin 
resistance, waist circumference, and concentrations of the 
procoagulatory substance PAI-1 and cytokines (Zitzmann 
et al. 2015)].
Finally, regarding epigenetic events, the supernumerary X 
chromosome in KS has an interesting effect on DNA meth-
ylation. Methylome studies in blood and brain samples have 
shown differences between KS patients and 46,XY males 
(Viana et al. 2014; Sharma et al. 2015; Wan et al. 2015; 
Skakkebaek et al. 2018). Unfortunately, only few overlap-
ping differentially methylated regions (DMRs) have been 
observed between studies, which could be in part explained 
by differences in the type of sample analyzed (blood vs 
brain) and the resolution of the arrays (Illumina 27 K vs Illu-
mina450K) (Skakkebaek et al. 2018 and references therein). 
Gene set enrichment analysis of the observed DMRs showed 
an overrepresentation of terms relevant to the KS pheno-
type such as diabetes, obesity, height, coronary and arterial 
disease, hypercholesterolemia, gingivitis and periodontitis, 
bone mineral density, cancer (breast, prostate, colon, pan-
creas, leukemia, lymphoma), connective tissue diseases, 
infection and inflammation and others (Skakkebaek et al. 
2018). However, it is still unknown whether these epigenetic 
alterations are responsible for the KS co-morbidities through 
altering gene expression regulation. In fact, only a moder-
ate correlation between epigenetic alterations and some of 
the phenotype-associated gene expression levels (BOLA1, 
DDX43, ZBTB44 and KDM5C) has been observed (Skakke-
baek et al. 2018). Further studies on different tissue samples 
are needed to elucidate the biological basis for the heteroge-
neous phenotypic presentation of KS.
Too little X: X‑linked deletions
Copy number variants (CNVs) are a type of structural vari-
ant involving alterations in the number of copies of specific 
regions of DNA (often defined as above 1 kb in length) in 
comparison with a reference genome (Feuk et al. 2006). The 
functional consequence of a CNV can be difficult to predict 
and depends on the exact position of the CNV breakpoint, 
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i.e., the region where a fragment was inserted (gain/duplica-
tion) or lost (loss/deletion). CNVs may affect gene function 
directly or indirectly. A direct effect through the involve-
ment of coding sequences may be the consequence of the 
CNV (i) altering the copy number of dosage-sensitive genes; 
(ii) disrupting the gene-coding sequence, as partial gain or 
deletion of coding sequences can produce different alleles, 
including both loss and gain of function; or (iii) produc-
ing chimeric proteins when CNV breakpoints lie within two 
different genes, leading to the fusion of two partial coding 
regions. An indirect effect may occur when CNVs lie in non-
coding regions and disrupt the function of genes through the 
deletion or transposition of critical regulatory elements, such 
as promoters, enhancers and silencers (Hurles et al. 2008).
A number of CNVs generate alleles with a pathogenic 
effect in andrology; the best examples of such a clear-cut 
effect are the Y-chromosomal AZF deletions (Krausz et al. 
2014; Krausz and Casamonti 2017). Comparative genomic 
hybridization (CGH) arrays (whole genome or X chromo-
some specific) have been employed to analyze patients with 
quantitative spermatogenic disturbances in five laboratories 
(Tüttelmann et al. 2011; Krausz et al. 2012; Stouffs et al. 
2012; Lopes et al. 2013; Yatsenko et al. 2015), and four of 
them provide information about X-linked CNVs (Tüttelmann 
et al. 2011; Krausz et al. 2012; Lopes et al. 2013; Yatsenko 
et al. 2015). Comparing the raw data of these studies, only 
few partially overlapping CNVs have been observed, which 
could be in part explained by differences in the resolution 
of the arrays (Krausz et al. 2015). The only consistent find-
ing of the available studies is that there is a significantly 
higher ‘burden’ of deletions, particularly on the X chromo-
some, in infertile men versus normozoospermic controls. 
The observed higher burden of X-linked deletions has been 
hypothesized to be an expression of a generalized genomic 
instability, which may also lead to general health problems. 
This hypothesis would be in line with the epidemiological 
observations showing a link between altered spermatogenic 
function and a higher incidence of morbidity (including can-
cer) and lower life expectancy (Jensen et al. 2009; Salonia 
et al. 2009; Eisenberg et al. 2014).
Besides the CNV burden, CGH arrays have allowed 
researchers to identify a few X-linked deletions with a pos-
sible role in male infertility (Krausz et al. 2015 and ref-
erences therein). Only one potential clinically relevant X 
chromosome-linked deletion has been analyzed in several 
studies. CNV67 was first described as patient specific in 
1.1% (7/627) of infertile men from Spain and Italy (Lo 
Giacco et al. 2014). A subsequent study in a Mediterranean 
population confirmed the role of the CNV67 in male infer-
tility, since it was found in 1.2% of infertile men but not in 
normozoospermic controls (Pinho et al. 2019). The CNV67 
has also been analyzed in the Chinese population with con-
troversial results. One study reported that 6/884 infertile 
patients carried the deletion, whereas it was not found in 
any of the 838 controls from Sichuan Province in south-
western China (Shen et al. 2017). On the contrary, Ma et al. 
(2017) reported the prevalence of the CNV67 to be about 
3% in fertile controls, but the controls had unknown sperm 
counts and belonged to a specific geographic area (the Guan-
dong population). The exact mechanism by which CNV67 
may alter spermatogenesis is still unknown. Studies have 
suggested that the CNV67 might cause a partial deletion of 
the proximal copy of the MAGEA9B gene, which is a CTA 
specifically expressed in the testis and in some tumors (Shen 
et al. 2017). In summary, further studies in multiple popu-
lations including fertile controls with known sperm counts 
are needed to elucidate the clinical relevance of this CNV.
X chromosome‑linked gene mutations 
in male infertility
Many X-linked genes are promising candidates as causes for 
infertility owing to their testicular expression and expected 
involvement in spermatogenesis. The advances in high-
throughput sequencing approaches have allowed for the 
identification of additional genetic factors in azoospermic 
patients either by targeted sequencing or exome sequenc-
ing. However, most studies have not been replicated so far, 
and the functional roles of most genes are still ill-defined. 
Furthermore, the repetitive nature of the X chromosome can 
complicate the detection of deleterious variants. Although 
several candidate genes have been postulated, the number of 
promising or definitively causative genes for male infertility 
remains low when assessed in a standardized way (Smith 
et al. 2017), as has recently been done by Oud and collogues 
(Oud et al. 2019); see Table 1.
Non‑obstructive azoospermia (NOA)
AR
The androgen receptor (AR) remains the best studied 
X-linked gene so far in the etiology of male infertility. The 
AR is critical for diverse developmental processes and gen-
erally functions as a DNA-binding transcription factor. Upon 
binding of steroid hormone ligands in the cytoplasm, the 
receptor translocates into the nucleus and then stimulates 
the expression of androgen-responsive genes. The phenotype 
of patients with mutations in AR is highly variable and var-
ies from complete androgen insensitivity syndrome (CAIS) 
with sex reversal to mild symptoms (Brinkmann 2001). 
Patients with mild androgen insensitivity syndrome (MAIS) 
in particular can have normal genitalia and isolated male 
infertility. Variants detected in infertile patients are mainly 
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missense mutations affecting the transactivation potential 
of the AR (Goglia et al. 2011; O’Hara and Smith 2015). 
However, of the great number of reported AR mutations 
(Gottlieb et al. 2012), only a small number have been clearly 
associated with azoospermia or oligozoospermia. Thus, AR 
mutations can be considered a rare cause of male infertility 
(Hiort et al. 2000; Ferlin et al. 2006).
Furthermore, the AR gene contains a polymorphic CAG 
repeat in exon 1. Repeats longer than 35 are associated with 
spinal and bulbar muscular atrophy (SBMA) and prostate 
cancer (McCrea et al. 2016; Cortes and La Spada 2018). 
Besides, the length of the polymorphic CAG repeat encod-
ing a polyglutamine stretch (8–35 in length) in the AR N-ter-
minal transactivation domain has been linked to male infer-
tility. The number of CAG repeats is inversely correlated 
with transcriptional activity in vitro (Tut et al. 1997; Ferlin 
et al. 2004). The association between the AR-CAG repeat 
and male infertility has been intensively studied, but effects 
seem to be small and are still debated. Longer CAG repeat 
lengths may be a risk factor for male infertility, although 
population studies with variation detection in healthy con-
trols argue against a strong association with unexplained 
male infertility, as concluded from large meta-analyses 
(Davis-Dao et al. 2007; Xiao et al. 2016). The transacti-
vation domain of the AR comprises a further polyglycine 
tract (10–30 in length) encoded by a repeat consisting of 
GGN trinucleotides. However, the functional effect of the 
polyglycine tract remains controversial (Jääskeläinen 2012; 
Grigorova et al. 2017).
Apart from AR, additional X-chromosomal genes have 
been postulated to be causative for male infertility, including 
TEX11, MAGEB4, RHOX and TAF7L.
Table 1  Overview of disease-associated X-linked genes with testis-specific expression in mice and humans
a Not in Oud et al. (2019) because published subsequently. Assessment according to same criteria by MV and FT independently
Gene Semen/testicular pheno-
type
Proposed functions Mouse phenotype Publications Level of evidence





Infertile; partial androgen 
insensitivity syndrome












Germ cell-specific mitosis No mouse model Okutman et al. (2017) Limited
 HAUS7 Severe oligozoospermia Meiotic chromosome 
alignment





Fertile Paduch et al. (2005) Limited
 RHOXF1/2 Oligozoospermia, severe Homeodomain transcrip-
tion factor
No mouse model Borgmann et al. (2016) No evidence
 TAF7L Non-obstructive azoo-
spermia
TFIID transcription factor Complete spermatogen-
esis; abnormal sperm 
number/morphology
Akinloye et al. (2007) No evidence
Phenotype: obstructive azoospermia/CBAVD
 ADGRG2 Congenital bilateral 




Infertile; obstructive Patat et al. (2016) Strong
 CLDN2 Obstructive azoospermia BTB tight junction forma-
tion
Fertile Askari et al. (2019) Limiteda
Phenotype: astheno-/teratozoospermia









malities of the sperm 
flagella
Baccetti et al. (2005), 
Visser et al. (2011)
Limited
 FATE1 Oligoasthenozoospermia SF1-dependent mitochon-
drial regulation




GnRH neuronal migration Infertile; hypogonado-
tropic hypogonadism
Gonçalves et al. (2017) Definitive
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TEX11
TEX11 encodes a protein that regulates DNA recombina-
tion and formation of chromosome synapses and crossovers 
(Adelman and Petrini 2008). The gene is highly expressed 
in late spermatocytes and in spermatids in mice (Wang et al. 
2001), and disruption of Tex11 in knock-out mice causes 
meiotic arrest and results in azoospermia (Yang et al. 2008). 
Recently, an intragenic TEX11 deletion removing exons 
10–12 was identified by high-resolution X-specific array-
CGH in two infertile patients with NOA due to meiotic 
arrest and mixed testicular atrophy, respectively (Yatsenko 
et al. 2015). Further analysis by targeted sequencing identi-
fied further TEX11 variants of which loss-of-function (LoF) 
mutations were associated with meiotic arrest, while the 
role of missense variants remains less clear (Yatsenko et al. 
2015; Yang et al. 2015a). Together, these data provide strong 
evidence that LoF variants in TEX11 cause non-obstructive 
azoospermia due to meiotic arrest also in human males.
MAGEB4
MAGEB4 is a type I melanoma antigen gene from the CTA 
family specifically expressed during germ cell differentiation 
with a yet-unclear function, although a role in murine germ 
cell-specific mitosis has been postulated (Osterlund et al. 
2000). This gene is part of a multicopy gene cluster of type 
I melanoma antigens (Lee and Potts 2017). In a single con-
sanguineous family, a stop-loss variant was segregated with 
azoospermia and oligozoospermia (Okutman et al. 2017). 
The evidence that this gene plays a causative role in NOA 
is currently very limited, as (i) the functional relevance of 
the described stop-loss variant is still unclear; (ii) no other 
variants in MAGEB4 have been identified so far; and iii) the 
role of other homologous MAGE family members remains 
elusive.
HAUS7
HAUS7 encodes a subunit of the human Augmin protein 
complex (Goshima et al. 2008) with a proposed function 
in chromosome alignment during meiosis. While a single 
HAUS7 variant has been described in a familial case of 
severe oligozoospermia (Li et al. 2018), its role in NOA 
pathology remains to be determined.
USP26
USP26 is a deubiquitylating enzyme with a transcription 
pattern restricted to the male germline (Wang et al. 2001). 
Several variants of unknown clinical significance were 
reported in azoospermic patients (Paduch et al. 2005; Ma 
et al. 2016; Luddi et al. 2016). However, reported missense 
and nonsense USP26 variants were also detected in fertile 
controls (Ravel et al. 2006; Christensen et al. 2008; Shi 
et al. 2011), and the functional impact of missense variants 
on enzyme activity appears to be low (Zhang et al. 2015; 
Liu et al. 2018). In vivo analysis of knock-out mice sug-
gests that Usp26 is dispensable for mouse gametogenesis 
(Felipe-Medina et al. 2019). Hence, convincing evidence 
for an association of USP26 variants with male infertility is 
currently lacking.
RHOX
RHOX genes belong to a large multicopy homeobox gene 
cluster (Maclean et al. 2005) and are expressed in male 
germ cells (Song et al. 2013). In severe oligozoospermic 
patients, variants were described in the genes RHOXF1 
and RHOXF2 (Borgmann et al. 2016). However, it remains 
unclear whether variants in a single RHOX gene could be 
causative for NOA, as other members of this large gene clus-
ter might have redundant roles (MacLean and Wilkinson 
2010). Further exploration of these ampliconic regions is 
necessary for a conclusive evaluation of pathogenicity.
TAF7L
The transcription factor TAF7L is expressed during meiosis 
with a dynamically regulated intracellular localization (Poin-
tud et al. 2003). Although Taf7l knock-out mice normally 
complete meiosis, they show reduced sperm production and 
abnormal sperm morphology (Cheng et al. 2007). Variants 
in TAF7L were described as risk factors for spermatogenic 
failure (Akinloye et al. 2007), although most variants were 
also found in fertile controls (Stouffs et al. 2006). Taken 
together, the disease association of TAF7L variants with 
azoospermia remains with no evidence.
Obstructive azoospermia
ADGRG2
Obstructive azoospermia can be caused by congenital 
bilateral absence of the vas deferens (CBAVD). In most 
CBAVD cases, recessive mutations are identified in the 
cystic fibrosis transmembrane conductance regulator 
gene (CFTR), and CFTR analysis by sequencing and 
screening for large rearrangements allows for a mutation 
detection rate of about 87% in CBAVD patients (Ratbi 
et  al. 2007). By exome sequencing of CFTR-negative 
CBAVD patients, LoF mutations were recently identified 
in the X-linked ADGRG2 gene (Patat et al. 2016), which 
encodes an adhesion G protein-coupled receptor that is 
specifically expressed in the epididymis and efferent ducts 
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(Obermann et al. 2003). Subsequently, further truncating 
and missense variants in ADGRG2 have been described 
(Yang et al. 2017; Yuan et al. 2019; Pagin et al. 2019). In 
accordance with human data, previous studies have already 
demonstrated that Adgrg2-knock-out male mice develop 
obstructive infertility (Davies et al. 2004). These studies 
established ADGRG2 as a novel gene responsible for a 
specific subtype of obstructive azoospermia. The molecu-
lar mechanism of X-linked CBAVD remains uncertain, 
although a regulation of fluid reabsorption by G-protein-
dependent CFTR coupling and β-arrestin-dependent recep-
tor internalization has been postulated (Zhang et al. 2018; 
Azimzadeh et al. 2019).
CLDN2
Recently, a CLDN2 missense variant was described in a 
family with several male relatives affected by obstructive 
azoospermia (Askari et al. 2019). The encoded protein 
Claudin-2 is a paracellular transmembrane protein, and 
the authors proposed a gain-of-function effect on the 
blood–epididymis barrier by the missense variant. How-
ever, Cldn2-knock-out mice are fertile, and CLDN2 was 
shown to be expressed in leaky epithelia, in contrast to 
barrier-forming claudins like CLDN1/4 (Muto et al. 2010). 
It remains to be shown whether CLDN2 variants can be 
responsible for obstructive azoospermia, e.g., by influenc-
ing the paracellular water transport in the epididymis.
Teratozoospermia and asthenozoospermia
PIH1D3
PIH1D3 (also known as CXorf41) encodes a protein 
which plays a role in preassembly of both outer (ODA) 
and inner (IDA) dynein arms of cilia and sperm flagella 
(Dong et al. 2014; Paff et al. 2017; Olcese et al. 2017). 
Point mutations and complete PIH1D3 gene deletions 
have been reported in patients affected by primary ciliary 
dyskinesia (PCD) (Paff et al. 2017; Olcese et al. 2017). 
PCD is a multisystemic disorder characterized by chronic 
respiratory tract infections, abnormally positioned internal 
organs and asthenozoospermia due to motility defects of 
cilia and flagella (Knowles et al. 2016). PCD can be caused 
by a number of genes, and transmission can be autosomal 
dominant, recessive or X-linked, with PIH1D3 as the only 
validated X-linked PCD gene. For PIH1D3 carriers, ICSI 
is an option. However, it should be noted that they are at 
risk for transmission of the entire spectrum of symptoms 
to the female offspring in case their partner is a heterozy-
gous carrier.
AKAP4
AKAP4 encodes a major structural component of sperm 
fibrous sheath (Turner et al. 1998). Intragenic deletions 
of the AKAP3 and AKAP4 genes were first described in a 
patient with total sperm immotility due to dysplasia of the 
fibrous sheath (DFS) (Baccetti et al. 2005). In 2011, an addi-
tional patient with DFS was reported carrying a hemizygous 
missense variant in AKAP4 (Visser et al. 2011). The Akap4-
defficient mice resemble the asthenozoospermic phenotype 
(Fang et al. 2019) observed in men. However, apart from 
these two case reports, AKAP4 mutations were not found in 
other cohorts of DFS patients, indicating currently limited 
evidence for this gene defect (Turner et al. 2001a, b; Yang 
et al. 2015b; Pereira et al. 2015).
FATE1
FATE1 belongs to the CTA family, and in 2003 it was 
sequenced in a cohort of 144 randomly selected infertile 
patients (Olesen et al. 2003). The authors reported two mis-
sense variants in two unrelated asthenozoospermic men. 
However, for one of the carriers a family study revealed that 
the variant was compatible with fertility; for the other one, 
the current bioinformatic tools predict the variant as benign. 
Therefore, given that no more cases have been reported since 
2003, it is highly unlikely that this gene plays an important 
role in male infertility.
Hypogonadotropic hypogonadism
ANOS1
ANOS1 (Xp22.31), previously called KAL1, encodes the 
anosmin-1 glycoprotein which is involved in the migration of 
GnRH neurons. ANOS1 point mutations and gene deletions 
are the most common cause of Kallmann syndrome, a rare 
endocrine disease characterized by both congenital hypog-
onadotropic hypogonadism (cHH) and hyposmia/anosmia. 
ANOS1 mutations and deletions may explain the phenotype 
in about 5–10% of cases (Balasubramanian and Crowley 
1993); in addition to ANOS1, mutations in more than 20 
autosomal genes can also lead to Kallmann syndrome.
The reproductive phenotype of patients affected by cHH 
may range from the complete form with absent puberty 
(usually associated with cryptorchidism, micropenis and 
gynecomastia) to late-onset HH (Krausz et al. 2018 and 
references therein). Other non-reproductive and non-olfac-
tory alterations described in KAL1 mutation carriers are 
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bimanual synkinesia (in about 80% of cases), unilateral 
renal dysgenesis (30%), arched palate, tooth agenesis, 
hearing impairment, pes cavus and ptosis, among others 
(Balasubramanian and Crowley 1993; Dode and Hardelin 
2009). Spermatogenesis is inducible with the administra-
tion of gonadotrophins, hence cHH patients may generate 
their own biological children either through natural con-
ception or assisted reproductive techniques. Preimplanta-
tion genetic testing in syndromic forms is advisable to 
prevent the transmission of the mutation.
Conclusions
Currently, validated X chromosome-linked monogenic 
causes of male infertility are surprisingly rare. From a 
total of eight genes studied in men with idiopathic oligo/
azoospermia, only AR and TEX11 reach sufficiently high 
clinical evidence for inclusion in diagnostic testing. On 
the other hand, targeted studies on highly specific infer-
tile phenotypes have successfully identified a novel gene 
for congenital absence of vas deferens (ADGRG2) and for 
complete asthenozoospermia due to primary ciliary dys-
kinesia (PIH1D3).
Although the X chromosome contains several structural 
elements which may predispose it to AZF-like deletions, 
only one deletion, CNV67, has been the object of multi-
ple validation studies. This deletion affects MAGEA9, an 
ampliconic gene belonging to one of the CTA gene fami-
lies. Similar to CNV67, the majority of X-linked deletions 
and duplications affect or remove CTA genes. These genes 
were independently acquired on the human X chromosome 
and are exclusively expressed in the testis in physiologi-
cal conditions. Based on their expression profile and their 
predicted involvement in cell proliferation (expression in 
various cancers), these genes are predicted to play a role in 
spermatogenesis. However, the interpretation of mutations 
in CTA genes is largely limited by their multicopy nature 
(implying possible compensation by the retained copies) and 
the lack of model animals (due to their exclusive presence in 
the human genome). Future, targeted studies are warranted 
on this specific group of peculiar genes.
The paucity of clinically relevant X-linked anomalies in 
oligo/azoospermia is in sharp contrast with the predicted 
specialization of this chromosome in male reproductive fit-
ness. Reasons for these disappointing results can be related 
to the fact that the majority of studies focusing on quantita-
tive impairment of spermatogenesis were based on Sanger 
re-sequencing of a few candidate genes. Ongoing exome 
analyses or whole X chromosome gene panel studies in large 
patient cohorts are likely to reveal novel X-linked genetic 
factors in the near future. A major challenge for the ongoing 
studies based on massive parallel sequencing remains the 
discovery and the demonstration of the pathogenic effect of 
mutations in multicopy spermatogenesis candidate genes.
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